Sovran Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Buy
2,871
+35
+1% +$3.12K 0.02% 502
2025
Q4
$239K Buy
+2,836
New +$222K 0.02% 493

Other funds holding CL

Sovran Advisors's CL Position: Q1 2026 in Review

Sovran Advisors increased its Colgate-Palmolive (CL) stake by 1.2% in Q1 2026, buying an estimated $3.12K and bringing the position to 2,871 shares worth $245K. The position accounts for 0.02% of the portfolio, ranked #502.

Sovran Advisors first reported a position in CL in Q4 2025 and has held it in 2 quarters since. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Sovran Advisors held 2,871 shares of Colgate-Palmolive worth $245K as of Q1 2026.
  • Sovran Advisors bought 35 Colgate-Palmolive shares in Q1 2026, an estimated $3.12K.
  • Colgate-Palmolive made up 0.02% of Sovran Advisors's portfolio in Q1 2026, its #502 holding.
  • Sovran Advisors first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 2 quarters since.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Sovran Advisors's 13F filing for Q1 2026, filed 1 May 2026.